Well it was sitting around 1 cent after the glypromate announcement and then it traded around 0.5 cent on the back of the director selling his holdings for about 1 week and now it has returned to slightly above 1 cent again (doubt it will warrant a "please explain" from the ASX).
I don't see any takeover activity just traders seeing a potential short term gain (which they got).
Company doesn't have much cash left in the kitty, but seeing as the phase III trials are over their expenditure should decrease significantly. They had a bit of difficulty raising funds last time round I guess this time may prove more problematic.
There should also be an announcement coming out on their number 2 drug in early February sometime.
Cheers
SBC
Well it was sitting around 1 cent after the glypromate...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.00 |
Change
0.090(0.45%) |
Mkt cap ! $2.556B | |||
| Open | High | Low | Value | Volume |
| $19.88 | $20.07 | $19.73 | $11.80M | 591.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5901 | $19.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.00 | 3262 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |